Rivfloza
Drug
Novo Nordisk AS
Total Payments
$1.1M
Transactions
984
Doctors
634
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.1M | 984 | 634 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $993,684 | 92 | 92.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,836 | 10 | 3.8% |
| Food and Beverage | $23,044 | 847 | 2.1% |
| Consulting Fee | $10,138 | 14 | 0.9% |
| Travel and Lodging | $9,454 | 20 | 0.9% |
| Space rental or facility fees (teaching hospital only) | $3,500 | 1 | 0.3% |
Payments by Type
Research
$993,684
92 transactions
General
$86,971
892 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DCR-PHXC-301 | Novo Nordisk AS | $637,689 | 0 |
| DCR-PHXC-204 | Novo Nordisk AS | $168,613 | 0 |
| DCR-PHXC-502 | Novo Nordisk AS | $104,877 | 0 |
| DCR-PHXC-203 | Novo Nordisk AS | $82,506 | 0 |
Top Doctors Receiving Payments for Rivfloza — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , NP | Nurse Practitioner | Boston, MA | $97.72 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Boston, MA | $97.72 | 1 |
| , MD | Urology | New Haven, CT | $96.30 | 1 |
| , MD | Nephrology | Los Angeles, CA | $96.21 | 1 |
| , C.N.S | Adult Health | Round Rock, TX | $93.84 | 4 |
| , FNP-C | Nurse Practitioner | Houston, TX | $91.10 | 4 |
| Jennifer Geotes | Pediatrics, Critical Care | Baltimore, MD | $88.97 | 1 |
| Alexandra Borden | Surgical | Greensboro, NC | $88.96 | 1 |
| , DNP, CPNP | Nurse Practitioner | Durham, NC | $88.96 | 1 |
| , BSN, RN, CPNP-PC | Nurse Practitioner | Durham, NC | $88.96 | 1 |
| , CPNP | Pediatrics | Baltimore, MD | $88.96 | 1 |
| , MD | Nephrology | Lufkin, TX | $88.11 | 1 |
| , APRN, CNS | Medical-Surgical | Tulsa, OK | $83.38 | 4 |
| , APRN | Pediatrics | Tulsa, OK | $83.35 | 4 |
| , M.D | Nephrology | Spartanburg, SC | $82.99 | 3 |
| , APRN | Registered Nurse | Houston, TX | $73.15 | 3 |
| , M.D | Urology | Oklahoma City, OK | $73.03 | 3 |
| , FNP-BC | Family | Savannah, GA | $72.07 | 3 |
| , M.D | Urology | Round Rock, TX | $68.38 | 3 |
| , M.D | Urology | Baltimore, MD | $67.32 | 3 |
| , M.D | Urology | Towson, MD | $67.30 | 3 |
| , DNP, FNP-C | Family | Bel Air, MD | $67.29 | 3 |
| , D.O., FACOI | Nephrology | Vineland, NJ | $64.51 | 3 |
| Siby Sebastian | Nurse Practitioner | Galveston, TX | $64.06 | 3 |
| , M.D | Internal Medicine | Bronx, NY | $63.09 | 3 |
Ad
Manufacturing Companies
- Novo Nordisk AS $993,684
- Novo Nordisk Inc $86,971
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 634
- Transactions 984
About Rivfloza
Rivfloza is a drug associated with $1.1M in payments to 634 healthcare providers, recorded across 984 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk AS.
Payment data is available from 2024 to 2024. In 2024, $1.1M was paid across 984 transactions to 634 doctors.
The most common payment nature for Rivfloza is "Unspecified" ($993,684, 92.0% of total).
Rivfloza is associated with 4 research studies, including "DCR-PHXC-301" ($637,689).